Sands Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History

Sands Capital Management, LLC

$31.4 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $150 Million - $199 Million	-1,276,613 Reduced 59.34%	874,765 $121 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $33.4 Million - $43.7 Million	-330,997 Reduced 13.33%	2,151,378 $279 Million
Q3 2022 Nov 09, 2022	SELL	$75.71 - $119.24 $93 Million - $147 Million	-1,228,726 Reduced 33.11%	2,482,375 $274 Million
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $67.2 Million - $94.8 Million	-1,071,850 Reduced 22.41%	3,711,101 $278 Million
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $36.7 Million - $52.6 Million	-581,676 Reduced 10.84%	4,782,951 $374 Million
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $15.6 Million - $20 Million	-201,476 Reduced 3.62%	5,364,627 $483 Million
Q3 2021 Nov 03, 2021	SELL	$65.97 - $92.48 $2.71 Million - $3.8 Million	-41,045 Reduced 0.73%	5,566,103 $515 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $179 Million - $224 Million	2,579,058 Added 85.17%	5,607,148 $436 Million
Q1 2021 May 12, 2021	BUY	$72.25 - $168.95 $148 Million - $347 Million	2,050,954 Added 209.89%	3,028,090 $226 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $112 Million - $159 Million	-888,327 Reduced 47.62%	977,136 $167 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $314 Million - $426 Million	-2,473,793 Reduced 57.01%	1,865,463 $262 Million
Q2 2020 Aug 11, 2020	SELL	$93.0 - $171.7 $5.92 Million - $10.9 Million	-63,675 Reduced 1.45%	4,339,256 $696 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $12.7 Million - $20.3 Million	-154,568 Reduced 3.39%	4,402,931 $431 Million
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $46.3 Million - $82.1 Million	605,409 Added 15.32%	4,557,499 $588 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $31.1 Million - $66.9 Million	426,514 Added 12.1%	3,952,090 $298 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $10.3 Million - $13.9 Million	-91,518 Reduced 2.53%	3,525,576 $536 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $55.7 Million - $79.2 Million	522,327 Added 16.88%	3,617,094 $431 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $116 Million - $178 Million	1,193,203 Added 62.75%	3,094,767 $338 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $219 Million - $307 Million	1,901,564 New	1,901,564 $307 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.

Account